SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-034095
Filing Date
2014-05-02
Accepted
2014-05-02 16:05:31
Documents
5
Period of Report
2014-05-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-11818_18k.htm 8-K 24774
2 EX-99.1 a14-11818_1ex99d1.htm EX-99.1 124464
3 GRAPHIC g118181mmi001.jpg GRAPHIC 16931
4 GRAPHIC g118181mmi002.jpg GRAPHIC 18151
5 GRAPHIC g118181mmi003.jpg GRAPHIC 18459
  Complete submission text file 0001104659-14-034095.txt   224622
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 14809425
SIC: 2834 Pharmaceutical Preparations